using mannosylated chitosan (MC) nanoparticles to form the FMDV-pVAC-VP1-OmpA
complex particles. These particles were characterized for their physical properties like
morphology, size and charge prior evaluating the actual vaccine delivery effect of MC-
nanoparticles. The immunological evaluation indicated that the 20 μg of DNA vaccine
complexed with MC nano-particles was found optimum in inducing the immune response in …